Cachexia

Oncology·MeSH: Cachexia

7 drugs in development·7 companies·4 clinical trials

Drug Pipeline by Phase

Phase 2(2)

Drug	Company
ph284	Vistagen Therapeutics, Inc. (VTGN)
ponsegromab	Merus N.V. (MRUS)

Phase 1(2)

Drug	Company
av-380	AVEO PHARMACEUTICALS, INC. (AVEO)
gb18	TC BioPharm (Holdings) plc (TCBWF)

Preclinical(3)

Drug	Company
Cannabics SR	CNBX Pharmaceuticals Inc. (CNBX)
fl-501	CYPHERPUNK TECHNOLOGIES INC. (CYPH)
regenerum	INNOVUS PHARMACEUTICALS, INC. (INNV)

BioSniper tracks 7 drugs in development for Cachexia across 7 companies.

There are 4 clinical trials targeting Cachexia tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.